Publications by authors named "Angelica Imitola"
Time in range and mean glucose cut-off points for reduction of fetal outcomes in pregnant women with type 1 diabetes using automated insulin delivery systems.
Diabetes Res Clin Pract
November 2024
Article Synopsis
- This study investigates how time in range (TIRp) and mean glucose levels during pregnancy impact fetal health in women with Type 1 Diabetes (T1D) using automated insulin delivery (AID) systems.* -
- The findings reveal that a TIRp below 59.1% and mean glucose over 133 mg/dL in the second trimester are linked to higher instances of fetal outcomes like large for gestational age (LGA) and hyperbilirubinemia.* -
- It suggests that improving TIRp, especially through the early use of advanced hybrid closed loop (AHCL) systems, could enhance fetal outcomes, although more research is required to solidify these recommendations.*
Background And Aims: Despite using sensor-augmented pump therapy (SAPT) with predictive low-glucose management (PLGM), hypoglycemia is still an issue in patients with type 1 Diabetes (T1D). Our aim was to determine factors associated with clinically significant hypoglycemia (<54 mg/dl) in persons with T1D treated with PLGM-SAPT.
Method: ology: This is a multicentric prospective real-life study performed in Colombia, Chile and Spain.
Efficacy and safety of sensor-augmented pump therapy (SAPT) with predictive low-glucose management in patients diagnosed with type 1 diabetes mellitus previously treated with SAPT and low glucose suspend.
Endocrinol Diabetes Nutr (Engl Ed)
October 2018
Background: Sensor-augmented insulin pump therapy (SAPT) with low-glucose suspend (LGS) is an effective and safe alternative for treating patients with type 1 diabetes mellitus (T1DM). New predictive low-glucose management (PLGM) systems decrease the severity and duration of hypoglycemic events. However, evidence of benefits in patients previously treated with SAPT-LGS is limited.
View Article and Find Full Text PDF